MI/25/44 Executive Assistant to Director of the Cancer Research UK Manchester Institute

Key Details

Job ID:
MI/25/44
Role:
Executive Assistant to Director of the Cancer Research UK Manchester Institute
Area:
Salary:
Circa £40,000 per annum (dependent upon experience)
Closing date:
28th August 2025

About the role

Are you a career Executive Assistant who thrives in a busy environment, delivers with precision, and builds trusted relationships at the highest level? Do you take pride in keeping things running smoothly, managing complex priorities, and being a vital member of a collaborative and mission-driven team?

This is an exciting opportunity to support Professor Samra Turajlic as she steps into the role of Director of the Cancer Research UK Manchester Institute. As Executive Assistant to the Director, you’ll be at the heart of a world-leading scientific institution—helping shape its next chapter.

You will lead on the delivery and operational management of the Director’s office, working proactively and flexibly in response to shifting demands and priorities. You will liaise with a diverse range of stakeholders – from scientists to funders and public figures. With outstanding organisation and judgment, you’ll coordinate a busy national and international schedule, manage high-level engagements, and project manage key initiatives with discretion and precision.

This is a demanding and rewarding role in an inclusive environment, home to a community of over 350 scientists, clinicians, students, and professional staff—united in their commitment to scientific excellence and accelerating progress for human health.

About you

You’ll have extensive experience supporting senior executives in complex organisations, along with exceptional communication skills, and the ability to anticipate needs and act with clarity and drive. You should be educated to degree level (or have equivalent relevant experience in a similar, fast-paced EA/PA role) along with:

  • Excellent IT skills and proficient in the use of Microsoft packages (Word, Excel, PowerPoint, Outlook and Teams).
  • Experience of successful delivery of internal projects and/or a multi-partner project.
  • Outstanding organisational and problem-solving skills, with a demonstrated ability to think strategically, anticipate challenges, and offer proactive solutions.
  • Excellent communication abilities, both written and verbal with experience of drafting clear and concise briefings, reports and other types of communication for a wide range of audiences including senior management, along with the ability to interact effectively with colleagues at all levels within the institute.
  • Experience of working within an academic, clinical or scientific environment is desirable but not essential. What matters most is your resilience, professionalism, and ability to support a leader operating at the pinnacle of global science.
Photograph of Professor Samra Turajlić
Immunofluorescence image of tissue
Image of the Paterson Building main entrance

More information

Professor Samra Turajlić

We are delighted to announce, along with Cancer Research UK, The University of Manchester and The Christie NHS Foundation Trust, the appointment of Professor Samra Turajlić as our new Institute Director.

Professor Turajlić has been an independent research group leader at The Francis Crick Institute since 2019 and is a consultant medical oncologist at The Royal Marsden NHS Foundation Trust and will commence her role as Institute Director on the 1st of September 2025.

Cancer Dynamics Group

As a multi-disciplinary group of cancer geneticists, computational biologists and clinician scientists we are using methods from evolutionary biology to understand the variable natural history of individual cancers, and most critically the emergence of metastases and drug resistance.

We are applying evolutionary principles to the question by studying the forces that shape cancer evolution and use this knowledge to improve patient outcomes.

We are focusing on two cancers, renal cell carcinoma (RCC), which is the most common type of kidney tumour, and melanoma, the most aggressive type of skin cancer. RCC and melanoma exhibit a wide spectrum of clinical behaviour, some are indolent, others extremely aggressive and we want to know how this relates to their evolutionary trajectory.

About CRUK Manchester Institute

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials. rnThe Institute has access to outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry.

Professor Samra Turajlić
Cancer Dynamics Group
About CRUK Manchester Institute

How to apply

To apply for this position please complete the online application via ‘Apply Now’ button to visit our secure job application site. Please ensure you detail the names of two referees and ensure you submit your CV* and Cover Letter before the closing date specified.

*In the ‘Publication and CV’ section, please upload only your CV and indicate your highest qualification.

 Please note this vacancy will close for applications at 11:59pm on the closing date specified.

Any question? Get in touch

Please enable JavaScript in your browser to complete this form.

Why choose Cancer Research UK Manchester Institute?

The Cancer Research UK Manchester Institute, an Institute of The University of Manchester, is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org),
the largest independent cancer research organisation in the world.

We are partnered with The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe, which is located adjacent to the CRUK MI Manchester Institute in South Manchester. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Careers that have a lasting impact on cancer research and patient care

We are always on the lookout for talented and motivated people to join us.  Whether your background is in biological or chemical sciences, mathematics or finance, computer science or logistics, use the links below to see roles across the Institute in our core facilities, operations teams, research groups, and studentships within our exceptional graduate programme.

Gloved hands filling a stripette white lab coat

Latest from CRUK MI

Cancer Research In the Paterson Building

Find out more about the facilities across the Institute

Leukaemia Immunology & Transplantation

The Leukaemia Immunology and Transplantation laboratory aim to develop a comprehensive strategy to prevent post-transplant relapse in patients treated with allogeneic haematopoietic stem cell transplantation – the only curative therapy for many patients with acute myeloid leukaemia (AML) and other poor-risk haematological malignancies.

Patient derived preclinical models reveal novel biology of SCLC

Immune detection of dying tumour cells can elicit cancer immunity when the host permits it

Cancer Research In the Paterson Building
Leukaemia Immunology & Transplantation
Patient derived preclinical models reveal novel biology of SCLC